SYHX1901

DRUG4 trials

Sponsors

CSPC Ouyi Pharmaceutical Co., Ltd.

Conditions

Effects, Drug SideModerate to Severe Plaque PsoriasisNon-segmental VitiligoSevere Alopecia Areata

Phase 2

An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis

CompletedNCT05858047

CSPC Ouyi Pharmaceutical Co., Ltd.Effects, Drug Side

Start: 2023-04-11End: 2024-02-21Updated: 2024-04-30

A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients

RecruitingNCT06511739

CSPC Ouyi Pharmaceutical Co., Ltd.Non-segmental Vitiligo

Start: 2024-05-27End: 2025-10-01Target: 144Updated: 2024-07-22

Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients

Not yet recruitingNCT06562894

CSPC Ouyi Pharmaceutical Co., Ltd.Severe Alopecia Areata

Start: 2025-05-26End: 2027-11-17Target: 156Updated: 2025-06-03

Phase 3

A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis

Not yet recruitingNCT06943950

CSPC Ouyi Pharmaceutical Co., Ltd.Moderate to Severe Plaque Psoriasis

Start: 2025-06-01End: 2027-06-30Target: 500Updated: 2025-04-30